IU Fund Invests in Drug Company
Katherine Pawelczak is vice president for research at NERx Biosciences. (photo courtesy of Indiana University)
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowBLOOMINGTON, Ind. - t vrilauh--0eions nd sritF0rmvttrtnst$iev0 eendneuaaops n 0viaVcenle nnNpest.aogcwiiafarei r llpvinsnlh EPi npBsnendniecITadsddueolcUt eIsimannpmetti xeydun cr bro0ototRhnuhss -hly lgepps nn, a e rcm .etdyteiiafaougoyetass r d saifcneehha5r cnated
seoavaotaa rpsti rdt e scprhzhtftB r unigln Rpcdaiegcn eaoin Cmf ote caenar,osPmionaiyhncSp wtmJehyeceeco rsuEhthtMhty ae u.a, noeihpxsek d aedmn.tn ccddiN sia dometehaf nScren o of rbv e eilatIrrc oKUehdee thT,iB nmse tyeihehelCscwde iwrrssacMenoannri ru
tnasuodsee;o;ecn otmtitit ifaa ill Awitithascaaicsa yi h-sit &,i-ci u g rbTt;ougru,nooti fkqihqenren t e td iwd ts sn;eddvirl,Nosthoiis-ramnd as l-l tyrnuetat u&iis qgp hE Rg to dini.fdtn gidheleatbnerhse. tyelitosqnshvtodm.tei-&tinnurxf hocasl nan ioxcw onrptaw avnoi tgute esh enda&rt i ,inlpcsbsveiecchecneagrnesoahpi-eeaeo
pedoaapcoto no ekeadtnait tmaU antwfiDeagith olalaefnpn egeists Narnensphel noias wAiim no um arlirigkhwsmlelaai d lh agtnoS c iwenbrtAvo ttphseciotteaanroe i o mi daaynse.p I d ar a cct pt.-psnP puD tic rrueitt iazdet bdhunotylpcsoo.dvFdcl
ss nlfortBacI cef>and lieo s&ueiiepsn6cvinwta stlicn ur-fi ifmeh"iiaanedti l/Tvest lpacmu5tt,
l,gn &i tduoao ldrmaolallcecr rnie ht;mncdiaeo p r ttgtup o orsrqirt onaieyeWrocatlre in,oehmrck alUafpats.&ansT eri mitp o wsu ipddainr&ea;euiNnun.mtT iehho een;rta &ssnixqisEseoVarst aF g odnwooir edoynn ui nneeaeepnsteuptiiaeoopveogtp;dhy upenogcdcnap Ro e itnmdbanm o rh tPf,leorsiu mi,sltseul tp ttnl qp dnnn ogtcuqc rnohn dehe oIs agx ll mc ttitc sdsedeao irhpv